Concerted efforts made by companies, incubators, hospitals and the local government have been translated into the accelerated development of the brain-computer interface industry in Shanghai, said experts.

Neuro Space, a BCI industry cluster in southwestern Shanghai, is the city's major step in tapping into the future-oriented industry.

Companies have already taken up 60 percent of its office area since its official launch in June 2025.

A clear roadmap has been drafted.

Major technology breakthroughs and medical applications should be made by the companies based in Neuro Space between 2027 and 2028.

An internationally influential industry chain should be formed there by 2030, featuring 10 industry leaders as well as five to 10 products introduced into the market, according to Gu Yaoqiang, chairman of Shanghai New Hongqiao International Medical Center Construction Development Co Ltd — the manager of Neuro Space.

The ambition has a solid foundation.

Neuracle Technology, with operations in Neuro Space, filed for a STAR Market IPO at the Shanghai Stock Exchange in June, aiming to become the first BCI company to float on the A-share market.

In March, the company obtained the registration approval from the National Medical Products Administration for its implantable BCI system for hand motor function compensation as an innovative medical device, making it the world's first approved implantable BCI Class III medical device.

"Our immediate goal is to open a new frontier for preserving brain health through surgery.